Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0774
    -0.0020 (-0.18%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2625
    +0.0003 (+0.03%)
     
  • USD/JPY

    151.3370
    -0.0350 (-0.02%)
     
  • Bitcoin USD

    69,866.39
    -487.73 (-0.69%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

5 Best Bargain PEG Stocks That Value Investors Love

Zacks.com featured highlights include: Twitter, Lockheed Martin, Intercontinental Exchange, CBRE and Keurig Dr Pepper

When it comes to value investing, the name that comes to the forefront is none other than Warren Buffett. The Oracle of Omaha’s fortune trail can be solely attributed to value investment. His success story, which started 60 years back, clearly underscores how value investment has helped him to transform less than $10,000 into a net worth of $91.1 billion till February 2018 (data per a CNBC article).

Traditionally, the simplest method to decide whether a stock is overvalued or discounted is to determine its price-to-earnings ratio (P/E) and compare it with the P/E of the market or peer group. If you find the stock’s P/E is higher than that of the market, you can conclude that it is an expensive bid and vice versa.

However, the problem arises when a stock apparently with an attractively lower P/E faces a dearth of catalysts to propel future growth. In such a case, if you buy the stock depending solely on its lower P/E, you might still end up paying more on the risk that the stock may falter soon. To avoid such value traps, Warren Buffett advises investors to focus on the earnings growth potential of a stock while judging the intrinsic value. And here lies the importance of a not-so-popular value investing metric, the PEG ratio.

The PEG ratio is defined as: (Price/Earnings)/Earnings Growth Rate

A low PEG ratio is always better for value investors.

While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.

Unfortunately, this ratio is often neglected due to investors’ limitation to calculate the future earnings growth rate of a stock.

There are some drawbacks to using the PEG ratio though. It doesn’t consider the very common situation of changing growth rates such as the forecast of the first three years at a very high growth rate followed by a sustainable but lower growth rate in the long term.

Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.

Here are some of the screening criteria for a winning strategy:

PEG Ratio less than X Industry Median

(P/E Ratio (using F1) less than X Industry Median (For more accurate valuation purpose.)

Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) (whether good market conditions or bad, stocks with a Zacks Rank #1 or #2 have a proven history of success.)

Market Capitalization greater than $1 Billion (This helps us to focus on companies that have strong liquidity)

Average 20 Day Volume greater than 50,000 (A substantial trading volume ensures that the stock is easily tradable.)

Percentage Change F1 Earnings Estimate Revisions (4 Weeks) greater than 5% (Upward estimate revisions add to the optimism, suggesting further bullishness.)

Value Score of less than or equal to B: Our research shows that stocks with a Style Score of A or B when combined with a Zacks Rank #1 #2 or #3 offer the best upside potential. 

Here are five out of 16 stocks that qualified the screening:

Jazz Pharmaceuticals plc JAZZ: This is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs. The stock can be an impressive value investment pick with its Zacks Rank #2 and a Value Score of B. Apart from a discounted PEG and P/E, the stock also has an impressive long-term expected growth rate of 16.7%.

Nutrisystem, Inc. NTRI: The company is a prominent name in the field of weight-loss industry. The company offers weight-loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. Apart from a Zacks Rank #2 and a Value Score of A, the company also has an impressive growth rate of 17.5% for the next five years.

ACCO Brands Corporation ACCO: This is one of the world's largest designers, marketers and manufacturers of branded academic, consumer and business products. The company has an impressive current-year growth rate of 14.3%. The stock has a Value Score of A and a Zacks Rank #2. You can see the complete list of today's Zacks #1 Rank stocks here.

FedEx Corporation FDX: The company provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services. Apart from a discounted PEG and P/E, the stock has a Value Score of B and holds a Zacks Rank #2.

Sykes Enterprises, Incorporated SYKE: The company provides multi-channel demand generation and global customer engagement services. It provides differentiated full lifecycle customer-engagement solutions and services globally. The stock carries a Zacks Rank #2 and has a Value Score of A. It also has an impressive long-term expected earnings growth rate of 13.2%.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Zacks Restaurant Recommendations: Inaddition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Jazz Pharmaceuticals PLC (JAZZ) : Free Stock Analysis Report
 
NutriSystem Inc (NTRI) : Free Stock Analysis Report
 
Acco Brands Corporation (ACCO) : Free Stock Analysis Report
 
FedEx Corporation (FDX) : Free Stock Analysis Report
 
Sykes Enterprises, Incorporated (SYKE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement